Your Swiss hub to european market access. As member of IGES group, we prepare and develop market access for phamaceuticals for e.g. Switzerland, Germany, UK, France or the Netherlands: E.g. product valuation, advice on trial design, HTA, reimbursement dossiers (e.g. AMNOG, HAS) & price negotiations.
- https://www.healthecon.iges.com/
- +41 61 284 9560
- stephan.ruckdaeschel@healthecon.iges.com
- Dr. Stephan Ruckdäschel
